Glyburide associated with more risk of adverse events than insulin in newborns

The medication glyburide, which has been increasingly used to treat gestational diabetes in pregnant women, was associated with higher risk for newborns to be admitted to a neonatal intensive care unit, have respiratory distress, hypoglycemia (low blood glucose), birth injury and be large for gestational age compared with infants born to women treated with insulin, according to a new article.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1NGRM7P